| DAA2424 |
C-type lectin domain family 3; member B decreases with age |
CLEC3B |
18.0% Decrease DNA Methylation |
dermis |
Human |
|
| DAA51 |
cut-like homeobox 2 |
CUX2 |
19.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA41 |
cyclin-dependent kinase 5 |
CDK5 |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA2423 |
cyclin-dependent kinase 5; regulatory subunit 1 decreases with age |
CDK5R1 |
17.2% Decrease DNA Methylation |
dermis |
Human |
|
| DAA444 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
CDKN1A |
50.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2063 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) decreases with age |
CDKN1C |
69.3% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
CDKN2B |
16.7% Decrease DNA Methylation |
mesenchymal stem cell |
Human |
|
| DAA2384 |
cyclin-dependent kinase inhibitor 2B isoform 2 increases with age |
CDKN2B |
26.0% Increase DNA Methylation |
dermis |
Human |
|
| DAA1072 |
CYFIP2 A to I mRNA editing decreases |
CYFIP2 |
Increase mRNA Editing |
frontal lobe |
Human |
|
| DAA38 |
cystathionine-beta-synthase |
CBS |
18.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA570 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
CRIM1 |
9.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA403 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
CRIM1 |
6.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA482 |
cytochrome c-1 |
CYC1 |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA415 |
cytochrome c oxidase subunit IV isoform 1 |
COX4I1 |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA569 |
cytochrome c oxidase subunit VIIb |
COX7B |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA329 |
cytochrome c, somatic |
CYCS |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA52 |
cytochrome P450, family 2, subfamily J, polypeptide 2 |
CYP2J2 |
9.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA489 |
cytochrome P450, family 4, subfamily X, polypeptide 1 |
CYP4X1 |
12.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA273 |
cytoplasmic FMR1 interacting protein 2 |
CYFIP2 |
11.0% Decrease Gene Expression Level |
kidney |
Human |
|
| DAA572 |
D-dopachrome tautomerase |
DDT |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA56 |
DEAD (Asp-Glu-Ala-As) box polypeptide 19B |
DDX19B |
9.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA293 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
DDX24 |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA57 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 |
DDX39 |
8.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA382 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
DDX42 |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA406 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 |
DDX59 |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|